ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992